OTC - ACTIVE INGREDIENT SECTION
Active ingredients (in each capsule)
Acetaminophen 162.5 mg
Chlorpheniramine maleate 2 mg
Dextromethorphan hydrobromide 10mg
Phenylephrine hydrochloride 5 mg
Active ingredients (in each capsule)
Acetaminophen 162.5 mg
Chlorpheniramine maleate 2 mg
Dextromethorphan hydrobromide 10mg
Phenylephrine hydrochloride 5 mg
Purposes
Acetaminophen Pain reliever-fever reducer
Chlorpheniramine maleate Antihistamine
Dextromethorphan hydrobromide Cough suppressant
Phenylephrine hydrochloride Nasal decongestant
Uses
■temporarily relieves these symptoms due to a cold, the flu, or hay fever:
■minor aches and pains ■headache ■sore throat ■nasal congestion
■runny nose ■sinus congestion and pressure
■cough due to minor throat and bronchial irritation
■sneezing, itching of the nose or throat, and itchy, watery eyes due to hay fever
■temporarily reduces fever
Warnings
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take:
■more than 12 capsules in 24 hours, which is the maximum daily amount for this product
■with other drugs containing acetaminophen
■3 or more alcoholic drinks everyday while using this product
Do not use
■ with any other drug containing acetaminophen (prescription or nonprescription). If you
are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
■ if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for
depression, psychiatric or emotional conditions, or Parkinson’s disease). If you do not
know whether a prescription drug contains an MAOI, ask a doctor or pharmacist.
■ for 2 weeks after stopping the MAOI drug
Ask a doctor before use if you have
■ liver disease ■ heart disease ■ high blood pressure ■ diabetes
■ thyroid disease ■ glaucoma
■ difficulty in urination due to enlargement of the prostate gland
■ a breathing problem such as emphysema or chronic bronchitis
■ a persistent or chronic cough such as occurs with smoking, asthma, or emphysema, or if cough is accompanied by excessive phlegm (mucus)
Ask a doctor or pharmacist before use if you are
■taking the blood thinning drug warfarin
■taking sedatives or tranquilizers
When using this product
■do not exceed recommended dosage
■may cause excitability especially in children
■do not drive or operate machinery
■avoid alcoholic beverages
■may cause marked drowsiness; alcohol, sedatives, and tranquilizers may increase the
drowsiness effect
Stop use and ask a doctor if
Do not give to children under 12 years of age unless directed by a doctor.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison
Control Center right away. Prompt medical attention is critical for adults as well as for
children even if you do not notice any signs or symptoms.
Directions
■adults and children 12 years of age and older: 2 capsules every 4 hours, while symptoms
persist, not to exceed 6 doses (12 capsules) in 24 hours, or as directed by a doctor
■children under 12 years of age: ask a doctor
Other information
■keep container tightly closed ■protect from light ■store between 15° to 30°C (59° to
86° F)
■each capsule contains calcium 10 mg
Inactive ingredients
dibasic calcium phosphate, FD and C Blue No. 2 Alminum lake, FD and C Yellow No. 6, FD and C
Yellow No. 6 Aluminum lake, gelatin, magnesium stearate, microcrystalline cellulose,
polysorbate 80, starch, talc, titanium dioxide, and wild cherry extract.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1242747 | acetaminophen 162.5 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG Oral Capsule | PSN | 8 |
| 1242747 | acetaminophen 162.5 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule | SCD | 8 |
| 1242747 | APAP 162.5 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule | SY | 8 |
| Class | Version | Type | Effective |
|---|---|---|---|
| CHLORPHENIRAMINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| DEXTROMETHORPHAN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PHENYLEPHRINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49873-113-01 | Stona-S | 1 in 1 CARTON | CAPSULE | 1 | 8 | |
| 49873-113-01 | Stona-S | 24 in 1 BOTTLE | CAPSULE | 24 | 8 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49873-113 | STONA-S (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE) CAPSULE [SATO PHARMACEUTICAL CO., LTD.] | 8 | Current NDC, Legacy NDC, 2 package rows | 20231205_2f4c2791-76ec-4f95-a50b-a1eb8dbc9bc1.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| acetaminophen | ACTIVE INGREDIENT | 362O9ITL9D | 3 | |
| chlorpheniramine maleate | ACTIVE INGREDIENT | V1Q0O9OJ9Z | 3 | |
| dextromethorphan hydrobromide | ACTIVE INGREDIENT | 9D2RTI9KYH | 3 | |
| phenylephrine hydrochloride | ACTIVE INGREDIENT | 04JA59TNSJ | 3 | |
| acetaminophen | ACTIVE MOIETY | 362O9ITL9D | 3 | |
| chlorpheniramine | ACTIVE MOIETY | 3U6IO1965U | 3 | |
| dextromethorphan | ACTIVE MOIETY | 7355X3ROTS | 3 | |
| phenylephrine | ACTIVE MOIETY | 1WS297W6MV | 3 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | 3 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 3 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | 3 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 3 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 3 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49873-113 | 49873-113-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | CAPSULE / ORAL | 4 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE / ORAL | 5785 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE / ORAL | 5785 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | CAPSULE / ORAL | 7 mg | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE / ORAL | 10932 mg | ||
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | CAPSULE / ORAL | 401 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE / ORAL | 418.37 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE / ORAL | 418.37 mg | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | CAPSULE / ORAL | 4 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | CAPSULE / ORAL | 7 mg | ||
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | CAPSULE / ORAL | 401 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE / ORAL | 729 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / ORAL | 72 mg | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE / ORAL | 10932 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE / ORAL | 729 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / ORAL | 72 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stona-S | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | Sato Pharmaceutical Co., Ltd. | 2f4c2791-76ec-4f95-a50b-a1eb8dbc9bc1 | 2023-12-04 | Warnings | 49873-113-01 49873-113 49873011301 0bb87850-ad34-ce89-e063-6294a90a421d 2f4c2791-76ec-4f95-a50b-a1eb8dbc9bc1 |
Adverse event summaries are temporarily unavailable. Other product information remains available.